The University of Udine has secured European funding of 4.5 million euros for a research project (Int2Act) focused on the development of innovative biotechnologies for next-generation diagnostics and therapies. The four-year research project, involving 25 international partners, is led by the Department of Medicine and coordinated by Carlo Vascotto, Professor of Molecular Biology. It involves the use of nucleic acids, fundamental molecules that store, transmit and express genetic information and which have opened up new clinical prospects: from cancer immunotherapy to the diagnosis of infectious diseases and the treatment of rare diseases.
Read the article
Innovative biotechnology
More news
8 April 2026 | NEWS
Ennio Morricone a musician of our time
18 March 2026 | NEWS
Low Tides: The Italian States-General at the University of Udine
16 March 2026 | NEWS
9.000 secondary school pupils attend the 31st edition of Student Day
11 February 2026 | NEWS
Innovating for growth: research, enterprise, and tools for competing
2 February 2026 | NEWS
PhD Day celebrates 99 new PhD graduates and eight winners of the PhD Award
2 February 2026 | NEWS
The iNEST project involved 36 researchers, including 11 coordinators
2 February 2026 | NEWS
Japan, joint double master's degree with the Kyoto Institute of Technology
2 December 2025 | NEWS
Development of innovative cancer therapies, international project
29 September 2025 | NEWS
Surfactants, Study by the University of Udine and Vienna University of Technology
3 September 2025 | NEWS
Gabriele Rizzetto is the University's new Director General
3 April 2025 | NEWS
Angelo Montanari is the new Rector of the University of Udine
17 March 2025 | NEWS
The Dialogue Between East and West: A Conversation with Kader Abdolah
19 February 2025 | NEWS
Massimo Recalcati and the Biblical Roots of Psychoanalysis